|
A non-surgical solution
for Degenerative Disc Disease
Intralink-Spine Inc. (ILS) is a company formed to develop,
manufacture, and bring to market a
revolutionary nonsurgical treatment for
Degenerative Disc Disease (DDD)
and the associated problem of low back pain.
Our proprietary technology,
NEXT
(Nonsurgical
EXogenous
crosslink
Therapy),
is engineered to reduce disc bulge under load and significantly strengthen
disc tissue, increasing its durability and tear resistance for immediate and
long term treatment of DDD and its
associated pathologies including Spinal Stenosis, Herniated Disks,
Post-Surgical Syndromes and Back Pain.
These problems affect over 15 million people each year in the US
alone. NEXT uses a tissue
revitalization reagent that can be injected into the spinal disc to
mechanically reinforce and stabilize the joint and decompress the surrounding
neural tissues without the need for invasive spinal surgery. NEXT is
based on the body’s own natural response to repair instability and
degradation of the spinal disc. The NEXT device instantly and directly
strengthens and stabilizes the disc, reducing the pain of the patient without
the costs and risks associated with surgery.
|
Latest News
Press Release 2.1.2010: INTRALINK-SPINE INC. AWARDED $750,000 SMALL BUSINESS INNOVATION RESEARCH PHASE II GRANT
Business Strategy
Click here to view an PDF Executive Summary
|